Literature DB >> 17055267

Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions.

Naoaki Fujii1, Jose J Haresco, Kathleen A P Novak, Robert M Gage, Nicoletta Pedemonte, David Stokoe, Irwin D Kuntz, R Kiplin Guy.   

Abstract

Novel small molecules were designed to specifically target the ligand-binding pocket of a PDZ domain. Iterative molecular docking and modeling allowed the design of an indole scaffold 10a as a reversible inhibitor of ligand binding. The 10a scaffold inhibited the interaction between MAGI-3 and PTEN and showed cellular activities that are consistent with the inhibition of NHERF-1 function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055267     DOI: 10.1016/j.bmcl.2006.10.006

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

Review 1.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Therapeutic use of PDZ protein-protein interaction antagonism.

Authors:  Nick X Wang; Ho-Jin Lee; Jie J Zheng
Journal:  Drug News Perspect       Date:  2008-04

Review 3.  Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.

Authors:  Xu Liu; Ernesto J Fuentes
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-28       Impact factor: 6.813

Review 4.  Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.

Authors:  Weiqiang Zhang; Naoaki Fujii; Anjaparavanda P Naren
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

5.  Functional regulation of cystic fibrosis transmembrane conductance regulator-containing macromolecular complexes: a small-molecule inhibitor approach.

Authors:  Weiqiang Zhang; Himabindu Penmatsa; Aixia Ren; Chandanamali Punchihewa; Andrew Lemoff; Bing Yan; Naoaki Fujii; Anjaparavanda P Naren
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

6.  Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1.

Authors:  Anders Bach; Nicolai Stuhr-Hansen; Thor S Thorsen; Nicolai Bork; Irina S Moreira; Karla Frydenvang; Shahrokh Padrah; S Brøgger Christensen; Kenneth L Madsen; Harel Weinstein; Ulrik Gether; Kristian Strømgaard
Journal:  Org Biomol Chem       Date:  2010-07-29       Impact factor: 3.876

7.  An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.

Authors:  Garima Tiwari; Debasisa Mohanty
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

Review 8.  Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases.

Authors:  Wiljan Hendriks; Annika Bourgonje; William Leenders; Rafael Pulido
Journal:  Molecules       Date:  2018-02-12       Impact factor: 4.411

9.  Small molecule inhibition of the Na(+)/H(+) exchange regulatory factor 1 and parathyroid hormone 1 receptor interaction.

Authors:  Jeremy M Fitzpatrick; Maria Pellegrini; Patrick R Cushing; Dale F Mierke
Journal:  Biochemistry       Date:  2014-09-15       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.